Thermo Fisher Scientific is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical ...

Updated Phase 3 analyses position PL9643 as a potential first-in-class therapy achieving full symptom resolution in dry eye disease. <li ...

In our oncology focus month, Ryan McGuire takes a look at the impact of clinical development on cancer drug prices ... through a single phase 1, phase 2 and phase 3 clinical trial." ...

The trial in Yale School of Medicine's Department of Psychiatry will be led by Dr. Anahita Bassir Nia, M.D., a specialist in substance abuse, including alcohol abuse. The trial will also be conducted ...

Oral presentation at ASCO to highlight topline Phase 2 data of elraglusib in combination with gemcitabine/nab-paclitaxel (GnP ...

Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody ... 1310 data at ASCO and outline the next steps in clinical development. Date/Time: Monday, June 2, 2025, at 7:00 a.m. CT ...

The hold, placed by the FDA on an early-stage clinical trial of an experimental BET inhibitor, stems from a recent ...

"We are excited about the potential of BDC-3042 to help patients with cancer. This initial dose-escalation study demonstrated ...

Phase 1 dose-escalation study to evaluate ziftomenib in combination with imatinib in patients with advanced GIST after imatinib failure - - Combination of ziftomenib and imatinib shows robust and dura ...

Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or ...